(19)
(11) EP 1 268 526 A2

(12)

(88) Date of publication A3:
17.01.2002

(43) Date of publication:
02.01.2003 Bulletin 2003/01

(21) Application number: 01922630.7

(22) Date of filing: 23.03.2001
(51) International Patent Classification (IPC)7C07K 14/00, G01N 33/53, A61K 38/00
(86) International application number:
PCT/US0109/410
(87) International publication number:
WO 0107/2962 (04.10.2001 Gazette 2001/40)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 24.03.2000 US 191929 P

(71) Applicant: Saatcioglu, Fahri
Wellesley, MA 02482 (US)

(72) Inventor:
  • Saatcioglu, Fahri
    Wellesley, MA 02482 (US)

(74) Representative: Bösl, Raphael, Dr. rer. nat., Dipl.-Chem. 
Patent- und RechtsanwälteBardehle . Pagenberg . Dost . Altenburg . Geissler . IsenbruckGalileiplatz 1
81679 München
81679 München (DE)

   


(54) NOVEL PROSTATE-SPECIFIC OR TESTIS-SPECIFIC NUCLEIC ACID MOLECULES, POLYPEPTIDES, AND DIAGNOSTIC AND THERAPEUTIC METHODS